Dr. Maddocks is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
460 W 10th Ave
5th Floor
Columbus, OH 43210Phone+1 614-293-3196Fax+1 614-293-4812- Is this information wrong?
Education & Training
- Ohio State University HospitalFellowship, Hematology and Medical Oncology, 2008 - 2011
- Mayo Clinic College of Medicine and Science (Rochester)Residency, Internal Medicine, 2005 - 2008
- University of South Dakota, Sanford School of MedicineClass of 2005
Certifications & Licensure
- OH State Medical License 2008 - 2024
- MN State Medical License 2006 - 2008
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013
Clinical Trials
- Rituxan/Bendamustine/PCI-32765 in Relapsed DLBCL, MCL, or Indolent Non-Hodgkin's Lymphoma Start of enrollment: 2011 Dec 07
- IMGN529 in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma and Chronic Lymphocytic Leukemia Start of enrollment: 2012 Jan 01
- PCI-32765 (Ibrutinib) in Treating Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, or B-cell Prolymphocytic Leukemia Start of enrollment: 2012 May 21
- Join now to see all
Publications & Presentations
PubMed
- Does TRIANGLE take down transplantation in mantle cell lymphoma?Peter Martin, Kami Maddocks> ;Lancet. 2024 May 2
- Prognostic relevance of circulating lymphoma cells at diagnosis in newly diagnosed follicular lymphoma patients.Subodh Bhatta, Qiuhong Zhao, Daniel Jones, Kaitlin Annunzio, Walter Hanel, Mackenzie Owen, Havi Rosen, Timothy J Voorhees, David A Bond, Yazeed Sawalha, Audrey M Sigmu...> ;Hematological Oncology. 2024 May 1
- Brentuximab Vedotin Plus Ibrutinib in Relapsed and Refractory Hodgkin Lymphoma.Ni-Chun Tsai, Joycelynne Palmer, Matthew Mei, Saro Armenian, Robert Chen, Steven Rosen, Stephen Forman, Leslie Popplewell, Larry Kwak, Peter Martin, Kami Maddocks, Dav...> ;Clinical Lymphoma, Myeloma & Leukemia. 2024 Apr 10
- Join now to see all
Journal Articles
- Update on Mantle Cell LymphomaKami Maddocks, MD, Blood
Abstracts/Posters
- Subgroup Analyses from L-Mind, a Phase II Study of Tafasitamab (MOR208) Combined with Lenalidomide in Patients with Relapsed or Refractory Diffuse Large B-Cell LymphomaKami J. Maddocks, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
- Brentuximab Vedotin (BV) and Lenalidomide (Len) in Relapsed and Refractory (r/r) Cutaneous (CTCL) and Peripheral (PTCL) T-Cell Lymphomas; A Planned Interim Analysis of...Kami J. Maddocks, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
- Outcome of Autologous Stem Cell Transplantation Following PD-(L)1 Based Salvage Therapy for Multiply Relapsed Patients with Classic Hodgkin LymphomaKami J. Maddocks, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
- Join now to see all
Lectures
- Emerging Paradigms to Address Unmet Needs in Relapsed/Refractory DLBCL61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
- Update of the single-arm phase II L-MIND study of MOR208 + lenalidomide (LEN) in relapsed/refractory diffuse large B-cell lymphoma (R-R DLBCL): Response rates in patie...2019 ASCO Annual Meeting - 6/1/2019
- Single-Arm Phase II Study of MOR208 Combined with Lenalidomide in Patients with Relapsed or Refractory Diffuse Large B-Cell Lymphoma: L-Mind2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
Press Mentions
- Comorbidities and Role of R-CHOP in DLBCLFebruary 7th, 2020
- Potential Ibrutinib Resistance Mechanisms Identified in CLLMarch 20th, 2015
Hospital Affiliations
- Ohio State University Wexner Medical CenterColumbus, Ohio
- The OSUCCC - JamesColumbus, Ohio
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: